DD GROUP Co.,Ltd. Logo

DD GROUP Co.,Ltd.

Operates a diverse portfolio of food service, amusement, and hotel brands.

3073 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区芝4−1−23 三田NNビル18F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DD GROUP Co., Ltd. is a multifaceted enterprise principally engaged in the food service and amusement sectors. The company's core activities involve the planning, management, and operation of a diverse portfolio of businesses, including themed restaurants, pubs, cafes, and amusement facilities. The group has also expanded its operations to include the hotel business. Emphasizing a "brand company" philosophy, DD GROUP is dedicated to the continuous creation and development of innovative brands. Through its various group companies, it manages over 100 distinct brands across an extensive network of locations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 09:00
M&A Activity
訂正意見表明報告書
Japanese 229.2 KB
2025-07-15 07:18
M&A Activity
意見表明報告書
Japanese 425.5 KB
2025-05-30 09:01
Governance Information
内部統制報告書-第29期(2024/03/01-2025/02/28)
Japanese 24.4 KB
2025-05-30 09:00
Registration Form
有価証券報告書-第29期(2024/03/01-2025/02/28)
Japanese 1.8 MB
2025-05-30 09:00
Registration Form
確認書
Japanese 9.0 KB
2025-05-30 04:00
Regulatory News Service
臨時報告書
Japanese 24.8 KB
2025-04-14 09:15
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2025-02-28 03:00
Post-Annual General Meeting Information
臨時報告書
Japanese 22.3 KB
2024-10-15 09:00
Interim Report
半期報告書-第29期(2024/03/01-2025/02/28)
Japanese 279.9 KB
2024-10-15 09:00
Interim Report
確認書
Japanese 9.0 KB
2024-07-12 09:00
Report Publication Announcement
確認書
Japanese 9.0 KB
2024-07-12 09:00
Quarterly Report
四半期報告書-第29期第1四半期(2024/03/01-2024/05/31)
Japanese 223.4 KB
2024-07-02 09:12
Major Shareholding Notification
変更報告書
Japanese 40.0 KB
2024-05-30 09:01
Governance Information
内部統制報告書-第28期(2023/03/01-2024/05/29)
Japanese 23.8 KB
2024-05-30 09:00
Registration Form
有価証券報告書-第28期(2023/03/01-2024/02/29)
Japanese 1.8 MB

Automate Your Workflow. Get a real-time feed of all DD GROUP Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DD GROUP Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Delta-Fly Pharma, Inc. Logo
Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.
Japan 4598
DENTSU GROUP INC. Logo
Global advertising & marketing firm integrating tech and consulting for brand growth.
Japan 4324
DGA S.A. Logo
Consulting, training, and EU-funded project services for public and private organizations.
Poland DGA
DIGITAL HOLDINGS,INC. Logo
Drives business DX with data-driven advertising, CRM consulting, and AI integration.
Japan 2389
DIGITALIFT Inc. Logo
Digital marketing firm providing programmatic ad operations and strategic consulting services.
Japan 9244
D.L.S.I. Logo
HR and recruitment services for temp, fixed-term, and permanent roles across industries.
France ALDLS
Investment firm leasing four Airbus A380s to Emirates for shareholder returns.
Guernsey N/A
Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.
Guernsey N/A
DreamCIS INC. Logo
A CRO providing clinical research services for pharma, biotech, and medical device industries.
South Korea 223250
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea 383930

Talk to a Data Expert

Have a question? We'll get back to you promptly.